Medix Biochemica  

Activities: Research & Development

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Finance

Medix Biochemica expands its infectious diseases antibody offering with acquisition of ViroStat

The acquisition significantly expands Medix Biochemica’s leading portfolio of IVD raw materials, brings complementary scientific capabilities and further strengthens its local presence in the US
Research & Development

Medix Biochemica broadens its capabilities in diagnostic base matrices with acquisition

The acquisition is another important step in the execution of Medix Biochemica’s strategy to be the first-choice raw material partner to the IVD industry and help customers’ goal to further consolidate their supply chain
Subscribe now